Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.
- Status
- TERMINATED
- Phase
- PHASE2
Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pediatric Pertussis in Ambulatory Settings
- Status
- RECRUITING
- Phase
- N/A
Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
- Status
- WITHDRAWN
- Phase
- PHASE4
Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)
- Status
- COMPLETED
- Phase
- PHASE3
FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2